Reuters logo
BRIEF-Endocyte presents data on two lead clinical programs at European society
October 10, 2016 / 12:47 PM / a year ago

BRIEF-Endocyte presents data on two lead clinical programs at European society

Oct 10 (Reuters) - Endocyte Inc :

* Endocyte presents data on two lead clinical programs at european society for medical oncology (ESMO) 2016 congress

* Endocyte Inc - both EC1456 and EC1169 have shown anti-tumor activity during dose escalation phase of their respective trials

* Endocyte Inc says EC1169 was well tolerated without causing dose-limiting Hematologic toxicity frequently associated with traditional chemotherapy Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below